In clear cell renal cell carcinoma (ccRCC), ALKBH5 expression was positively correlated with the length of overall survival, indicating that ALKBH5 could be used as a prognostic biomarker (181). This evidence concerns the gene ALKBH5 and nonpapillary renal cell carcinoma.